The Brain Injury Research Center at Icahn School of Medicine at Mount Sinai
New York, 10029, United States
NCT Number: NCT03479606
This study will examine the efficacy of an emotion regulation intervention delivered online to individuals with traumatic brain injury (TBI) with deficits in emotion regulation. 104 subjects will be enrolled and will receive 24, 60-minute emotion regulation skills-training sessions twice a week for 12 weeks, delivered online in a group video-conference with 3-5 other participants. Participants will be asked to complete online surveys, lasting approximately 40-50 minutes, every four weeks during the intervention and the 12-week follow-up phase. Attendance and compliance will be tracked, and outcomes will be monitored using online data collection methods.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
New York, 10029, United States
This study will assess the efficacy of an emotion regulation skills-training intervention (Online EmReg) provided online to individuals with TBI with emotion regulation difficulties. Specifically, this study seeks to accomplish three aims: 1) Evaluate the efficacy of the Online EmReg intervention immediately post-intervention and at a 12-week follow-up assessment; 2) Identify factors that optimize the effectiveness of the Online EmReg intervention; 3) Explore the impact of Online EmReg on positive and negative affect, life satisfaction, and executive functioning. The study design is a randomized control trial with a waitlist control group whereby the participants in the control group undergo the training after a 12 week waiting period. 104 subjects with TBI and self-reported deficits in emotion regulation will be enrolled.
The intervention protocol calls for 24, 60-minute emotion regulation sessions twice a week for 12 weeks, delivered online via Zoom by post-doctoral level therapists with specialty training in rehabilitation neuropsychology. Study participation will last approximately 28 weeks for participants in the immediate intervention arm (4 weeks preparation, 12 weeks intervention, 12 weeks follow-up) and 40 weeks for participants in the waitlist arm (4 weeks preparation, 12 weeks waitlist, 12 weeks intervention, and 12 weeks follow-up). Core assessments will be conducted at each major time point: T1 (baseline), T2 (immediate intervention end/waitlist baseline), T3 (immediate intervention follow-up/end of waitlist intervention), and T4 (waitlist follow-up). A subset of the measures will be administered every 4 weeks between each major time point for the duration of the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Emotion Regulation Training (EmReg) is a cognitive-behavioral approach which aims to increase awareness, and self-monitoring of affective states to improve self-regulation. The intervention is divided into two phases: knowledge provision and practice facilitation. During the knowledge provision phase participants are introduced to the objectives and the main concepts of the intervention, to increase their familiarity with the terminology, and to the emotion regulation skills they acquire during the practice facilitation phase. During the practice facilitation phase participants receive training in emotion regulation skills, which they practice in-session with the guidance of the therapist and feedback from the group, as well as out-of-session as homework assignments.
Other names: Emotion Regulation Training (EmReg)
Time frame: Every 4 weeks for 28 or 40 weeks
36-item self-report questionnaire that focuses on emotional awareness, acceptance, ability to control impulsivity, and flexible use of strategies.
Time frame: Every 4 weeks for 28 or 40 weeks
A 20-item measure with two independent scales, positive affect and negative affect.
Time frame: Every 4 weeks for 28 or 40 weeks
A 5-item measure of satisfaction with life globally.
Time frame: Every 4 weeks for 28 or 40 weeks
A 35-item self-report measure assessing problem solving behavior and attitudes, the PSI yields 3 subscales: Approach/Avoidance Style, Problem Solving Confidence, and Presence of Personal Control.
Time frame: Every 4 weeks for 28 or 40 weeks
A 20-item sensitive and ecologically valid questionnaire assessing everyday problems.
Time frame: End of intervention (at 16 or 28 weeks) and follow-up at 12-weeks post intervention
These ratings are used to assess change on problems that are intervention targets, from the participant's point of view, by reporting how much better/worse the problem seems to be since the onset of the intervention.
Time frame: Every 4 weeks for 28 weeks
During the first 2 sessions, participants will be asked to set three to five personal goals related to emotional regulation and its impact on their daily lives, and then asked to rate their progress towards these goals on a 7-point Likert scale.
Time frame: End of intervention (at 16 or 28 weeks) and follow-up at 12-weeks post intervention
A 20-question content-based quiz developed to assess how well participants learn and retain EmReg concepts and strategies by intervention end.
Time frame: Baseline
A brief questionnaire to assess participants' access to rehabilitation services using modified items borrowed from national health surveys.
Icahn School of Medicine at Mount Sinai
Other
A Randomized Controlled Trial of an Online Emotion Regulation Intervention Following TBI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01730261
Behavior, Brain Diseases
New York, United States
View Trial DetailsNCT02613936
Behavior, Behavioral Symptoms
Albuquerque, New Mexico, United States
View Trial DetailsNCT05933629
Behavior, Brain Diseases
New York, United States
View Trial DetailsNCT01287156
Brain Diseases, Brain Injuries
Washington D.C., District of Columbia, United States
View Trial Details